L-arginine exposure improves renal function markers of metabolic syndrome in female rats

American Journal of Biochemistry and Molecular Biology

Volumn 3, Issue 1, 2013, Pages 50-60

  Cemaluk Egbuonu, A C ^a   Ezeanyika, L U S ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

Albumin; L arginine; Metabolic syndrome; Renal function; Urea

Indexed keywords

ALBUMIN; ARGININE; CREATININE; UREA;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; GLOMERULUS; KIDNEY DYSFUNCTION; METABOLIC SYNDROME X; MORPHOMETRICS; NONHUMAN; RAT; RENAL SYSTEM PARAMETERS; SERUM ALBUMIN CREATININE RATIO; UREA BLOOD LEVEL;

EID: 84867280723     PISSN: 21504210     EISSN: 21504253     Source Type: Journal    
DOI: 10.3923/ajbmb.2013.50.60     Document Type: Article

References (42)

1. Adeniran, O.Y., M.A. Fafunso, O. Adeyemi, A.O. Lawal, A. Ologundudu and A.A. Omonkhua, 2006. Biochemical effects of pesticides on serum and urinological system of rats. J. Applied Sci., 6: 668-672.
2. Alexander, B.T., M.T. Llinas, W.C. Kruckeberg and J.P. Granger, 2004. L-Arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure. Hypertension, 43: 832-836.
3. Alexander, R.H. and J.M. Grifith, 1992. Clinical/Nutritional Biochemistry. In: Basic Biochemical Methods, Alexander, R.H. and J.M. Grifith (Eds.). 2nd Edn., John Wiley and Sons Inc., New York, USA., pp: 181-317.
4. Appel, L.J., J. Middleton, E.R. Miller, M. Lopkowitz and K. Norris et al., 2003. The rationale and design of the AASK cohort study. J. Am. Soc. Nephrol., 14: S166-S172.
5. Atangwho, J.J., P.E. Ebong, M.U. Eteng, E.U. Eyong and A.U. Obi, 2007. Effect of Vernonia amygdalina del leaf on kidney function of diabetic rats. Int. J. Pharmacol., 3: 143-148.
6. Azhar, S., 2010. Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease. Future Cardiol., 6: 657-691.
7. Bakoma, B., K. Eklu-Gadegkeku, A. Agbonon, K. Aklikokou, E. Bassene and M. Gbeassor, 2011. Preventive effect of Bridelia ferrugineaagainst high-fructose diet induced glucose intolerance, oxidative stress and hyperlipidemia in male wistar rats. J. Pharmacol. Toxicol., 6: 249-257.
8. Capasso, I., E. Esposito, F. Pentimalli, A. Crispo and M. Montella et al., 2011. Metabolic syndrome affects breast-cancer risk in postmenopausal women: National Cancer Institute of Naples experience. Cancer Biol. Ther., 10: 1240-1243.
9. Cerasola, G., M. Guarneri and S. Cottone, 2009. Inflammation, oxidative stress and kidney function in arterial hypertension. G. Ital. Nefrol., 26: 8-13.
10. D'Apolito, X. Du, H. Zong, A. Catucci and L. Maiuri et al., 2010. Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J. Clin. Invest., 120: 932-942.
11. Demirovic, J.A., A.B. Pai and M.P. Pai, 2009. Estimation of creatinine clearance in morbidly obese patients. Am. J. Health-Syst. Pharm., 66: 642-648.
12. Egbuonu, A.C.C., C.A. Ezeokonkwo, P.M. Ejikeme, O. Obidoa and L.U.S. Ezeanyika, 2010. Some biochemical effects of sub-acute oral administration of L-arginine on monosodium glutamate-fed wistar albino rats 2: Serum alkaline phosphatase, total acid phosphatase and aspartate aminotransferase activities. Asian J. Biochem., 5: 89-95.
13. Egbuonu, A.C.C., L.U.S. Ezeanyika, P.M. Ejikeme and O. Obidoa, 2010. Histomorphologic alterations in the liver of male wistar rats treated with l-arginine glutamate and monosodium glutamate. Res. J. Environ. Toxicol., 4: 205-213.
14. Egbuonu, A.C.C., O. Obidoa, C.A. Ezeokonkwo, P.M. Ejikeme and L.U.S. Ezeanyika, 2010. Some biochemical effects of sub-acute oral administration of L-arginine on monosodium glutamate-fed Wistar albino rats 1: Body weight change, serum cholesterol, creatinine and sodium ion concentrations. Toxicol. Environ. Chem., 92: 1331-1337.
15. Ezeanyika, L.U.S. and A.C.C. Egbuonu, 2011. Impact of nitric oxide and insulin resistance on the pathophysiology of the metabolic syndrome: Possible role of L-arginine and glutamate. J. Med. Med. Sci., 2: 657-662.
16. Farrag, A.R.H. and S.E.M. Shalby, 2007. Comparative histopathological and histochemical studies on igr, lufenuron and profenofos insecticide albino rats. J. Applied Sci. Res., 3: 377-386.
17. Gallagher, E.J., D. Leroith and E. Karnieli, 2010. Insulin resistance in obesity as the underlying cause for the metabolic syndrome. Mt. Sinai J. Med., 77: 511-523.
18. Garlichs, C.D., J. Beyer, H. Zhang, A. Schmeisser and K. Plotze et al., 2000. Decreased plasma concentrations of L-hydroxy-arginine as a marker of reduced NO formation in patients with combined cardiovascular risk factors. J. Lab. Clin. Med., 135: 419-425.
19. Harisa, G.E.D.I., 2011. L-arginine ameliorates arylesterase/paraoxonase activity of paraoxonase-1 in hypercholesterolemic rats. Asian J. Biochem., 6: 263-272.
20. Hjelmesaeth, J., J. Roislien, N. Nordstrand, D. Hofso, H. Hager and A. Hartmann, 2010. Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: A cross-sectional study. BMC Endocrine Disorders, Vol. 10, 10.1186/1472-6823-10-6
21. Khan, S., 2010. Albumin creatinine ratio. http://www.buzzle.com/articles/albumin-creatinine-ratio.html.
22. Kilic, S., N. Yilmaz, G. Erdogan, M. Aydin, N. Tasdemir, M. Doganay and S. Batioglu, 2010. Effect of non-oral estrogen on risk markers for metabolic syndrome in early surgically menopausal women. Climacteric, 13: 55-62.
23. Lokhande, P.D., B.S. Kuchekar, A.R. Chabukswar and S.C. Jagdale, 2006. Nitric oxide: Role in biological system. Asian J. Biochem., 1: 1-17.
24. Mahajan, R., K. Gupta and V. Kapoor, 2010. A systematic account of pathogenesis, diagnosis and pharmacotherapy of metabolic syndrome: Things we need to know. Int. J. Pharmacol., 6: 338-345.
25. Mangat, C., N.K. Goel, D.K. Walia, N. Agarwal and M.K. Sharma et al., 2010. Metabolic syndrome: A challenging health issue in highly urbanized union territory of North India. Diabetol. Metab. Syndrome, Vol. 2, 10.1186/1758-5996-2-19
26. Marshal, W.E., 1994. Amino Acids, Peptides and Proteins. In: Functional Foods: Designer Foods, Pharmafoods, Nutraceuticals, Goldberg, I. (Ed.). Chapman and Hall, New York, USA., ISBN-13: 9780412988516, pp: 242-260.
27. Mathur, R., 2010. Metabolic syndrome. http://www.medicinenet.com/metabolic_syndrome/article.htm.
28. McGrowder, D. and P.D. Brown, 2007. Effect of nitric oxide on glucose transport: In vivo and in vitro studies. Asian J. Biochem., 2: 1-18.
29. Mugnai, G., 2010. Pathophysiological links between obstructive sleep apnea syndrome and metabolic syndrome. G. Ital. Cardiol. Rome, 11: 453-459.
30. Nitta, K., 2010. Possible link between metabolic syndrome and chronic kidney disease in thedevelopment of cardiovascular disease. Cardiol. Res. Pract., 10.4061/2011/963517
31. Ochei, J. and A. Kolhatkar, 2008. Medical Laboratory Science: Theory and Practice. Tata McGraw Hill Publishing Co. Ltd., New York, USA., ISBN-13: 978-0074632239, pp: 1364.
32. Ravikiran, M., A. Bhansali, P. Ravikumar, S. Bhansali and P. Dutta et al., 2010. Prevalence and risk factors of metabolic syndrome among Asian Indians: A community survey. Diabetes Res. Clin. Pract., 89: 181-188.
33. Rosato, V., A. Zucchetto, C. Bosetti, L. Dal Maso and M. Montella et al., 2011. Metabolic syndrome and endometrial cancer risk. Ann. Oncol., 22: 884-889.
34. Schriek, S., C. Ruckert, D. Staiger, E.K. Pistorius and K.P. Michel, 2007. Bioinformatic evaluation of L-arginine catabolic pathways in 24 cyanobacteria and transcriptional analysis of genes encoding enzymes of L-arginine catabolism in the cyanobacterium Synechocystis sp. PCC 6803. BMC Genomics, 8: 437-537.
35. Sepehri, G., S. Vahid, B. Fariba and F. Rasoul, 2006. Effect of L-NAME/L-arginine microinjection into nucleus accumbens shell on morphine withdrawal signs in male rats. Int. J. Pharmacol., 2: 171-176.
36. Siddiqui, A.A., 2011. Metabolic syndrome and its association with colorectal cancer: A review. Am. J. Med. Sci., 341: 227-231.
37. Subratty, A.H., L.H. Semfa and M.D. Manraj, 2007. TAME-esterase and oxidative stress contribute to dysmetabolic syndrome in dyslipidaemia. Asian J. Biochem., 2: 323-329.
38. Titty, F.V.K., W.K.B.A. Owiredu and M.T. Agyei-Frempong, 2008. Prevalence of metabolic syndrome and its individual components among diabetic patients in Ghana. J. Boil. Sci., 8: 1057-1061.
39. Uboh, F.E., E.N. Asuquo, M.U. Eteng and E.O. Akpanyung, 2011. Endosulfan-induces renal toxicity independent of the route of exposure in rats. Am. J. Biochem. Mol. Biol., 1: 359-367.
40. Wilding, P. and J.H. Kennedy, 1977. Manual of Routine Methods in Clinical Chemistry for use in Intermediate Laboratories. World Health Organization, Geneva, Switzerland, pp: 25-26.
41. World Medical Association/American Physiological Society, 2002. Guiding principles for research involving animals and human beings. Am. J. Physiol. Regul. Integr. Comp. Physiol., 283: R281-R283.
42. Zanna, H., S. Adeniji, B.B. Shehu, S. Modu and G.M. Ishaq, 2008. Effects of aqueous suspension of the root of Hyphaene thebaica (L.) mart on some indicators of liver and kidney function in rats. J. Pharmacol. Toxicol., 3: 330-334.